Thus, our data suggests that KFL8 plays a key role in regulating CSCs phenotypes in vitro, forms a feed-forward regulation with OGT, regulates triple negative breast tumor growth in vivo and associates with poor clinical outcome in breast cancer patients. This evidence concerns the gene OGT and breast cancer.